)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Anavex Life Sciences
Anavex Life Sciences (AVXL) investor relations material
Anavex Life Sciences TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.TD Cowen 46th Annual Health Care Conference summary2 Mar, 2026
Key scientific and clinical insights
Focus on oral, personalized treatments for CNS diseases, especially Alzheimer's and dementia, addressing a major unmet need.
Phase IIb/III trial of blarcamesine showed 36% improvement in ADAS-Cog13, rising to nearly 50% in a pre-specified population over 48 weeks.
Reliable safety profile with no ARIA or drug-related deaths, and significant slowing of brain atrophy observed.
Biomarker outcomes, including plasma Abeta 42 ratio, corroborated clinical results.
Mechanism centers on restoring autophagy and reducing cellular stress, with genetic precision medicine approaches enhancing efficacy.
Pipeline and development plans
Pipeline includes blarcamesine for Alzheimer's, Parkinson's disease dementia, Rett syndrome, Fragile X, and other rare CNS disorders.
ANAVEX 3-71 completed phase II in schizophrenia, with plans to advance in frontotemporal dementia.
Upcoming milestones: EMA re-examination review, new Alzheimer's and Parkinson's studies, and three imminent publications.
Precision medicine findings highlight COL24A1 and sigma-1 wild type genes as key to optimal response.
Plans for further studies in Fragile X, rare diseases, and preclinical work in infantile spasm and Angelman syndrome.
Commercial and operational highlights
Oral formulation offers convenience for patients and caregivers, reducing logistical and financial burdens.
No debt, over $131 million in cash, and a projected runway of more than three years.
Strong IP protection through 2040 and non-dilutive funding from major foundations.
Targeting large markets in the US and Europe for Alzheimer's, Parkinson's, schizophrenia, and rare diseases.
Engaging with care advisory groups to educate and strategize for patient-centric solutions.
Update on EMA re-examination for blarcamesine
Commercial strategy for precision AD population
Prioritize blarcamesine's non-AD pipeline
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Anavex Life Sciences earnings date
Q2 202612 May, 2026
Anavex Life Sciences
Next Anavex Life Sciences earnings date
Q2 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. The company's lead drug candidate is 2-73 that has completed phase II clinical trial for the treatment of Alzheimer's disease. Its programs also includes ANAVEX 3-71, which is in pre-clinical testing for the treatment of amyotrophic lateral sclerosis disease; and ANAVEX 1-41, a pre-clinical stage small molecule compound for the treatment of epilepsy.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage